CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Cantor Fitzgerald Adjusts Price Target on Amgen to $400 From $350, Maintains Neutral Rating

Neutral
AI Analysis

Summary

Cantor Fitzgerald raised its price target on Amgen from $350 to $400 while maintaining a neutral rating on the stock.

Importance:2/10
Sentiment:
0.00
price target adjustmentanalyst ratingequity research
Related Companies

Read the original article

Published by yahoo_finance on August 18, 2026 9:17 AM

Read Original